These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29511333)

  • 1. Relapse prediction in schizophrenia through digital phenotyping: a pilot study.
    Barnett I; Torous J; Staples P; Sandoval L; Keshavan M; Onnela JP
    Neuropsychopharmacology; 2018 Jul; 43(8):1660-1666. PubMed ID: 29511333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
    Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J
    Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.
    Buck B; Scherer E; Brian R; Wang R; Wang W; Campbell A; Choudhury T; Hauser M; Kane JM; Ben-Zeev D
    Schizophr Res; 2019 Jun; 208():167-172. PubMed ID: 30940400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks.
    Adler DA; Ben-Zeev D; Tseng VW; Kane JM; Brian R; Campbell AT; Hauser M; Scherer EA; Choudhury T
    JMIR Mhealth Uhealth; 2020 Aug; 8(8):e19962. PubMed ID: 32865506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomaly detection to predict relapse risk in schizophrenia.
    Henson P; D'Mello R; Vaidyam A; Keshavan M; Torous J
    Transl Psychiatry; 2021 Jan; 11(1):28. PubMed ID: 33431818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial.
    Lewis S; Ainsworth J; Sanders C; Stockton-Powdrell C; Machin M; Whelan P; Hopkins R; He Z; Applegate E; Drake R; Bamford C; Roberts C; Wykes T
    J Med Internet Res; 2020 Aug; 22(8):e17019. PubMed ID: 32788150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CrossCheck: Integrating self-report, behavioral sensing, and smartphone use to identify digital indicators of psychotic relapse.
    Ben-Zeev D; Brian R; Wang R; Wang W; Campbell AT; Aung MSH; Merrill M; Tseng VWS; Choudhury T; Hauser M; Kane JM; Scherer EA
    Psychiatr Rehabil J; 2017 Sep; 40(3):266-275. PubMed ID: 28368138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study.
    Cohen A; Naslund JA; Chang S; Nagendra S; Bhan A; Rozatkar A; Thirthalli J; Bondre A; Tugnawat D; Reddy PV; Dutt S; Choudhary S; Chand PK; Patel V; Keshavan M; Joshi D; Mehta UM; Torous J
    Schizophrenia (Heidelb); 2023 Jan; 9(1):6. PubMed ID: 36707524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.
    Eisner E; Bucci S; Berry N; Emsley R; Barrowclough C; Drake RJ
    Schizophr Res; 2019 Jun; 208():105-113. PubMed ID: 30979665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Phenotyping in Patients with Spine Disease: A Novel Approach to Quantifying Mobility and Quality of Life.
    Cote DJ; Barnett I; Onnela JP; Smith TR
    World Neurosurg; 2019 Jun; 126():e241-e249. PubMed ID: 30797933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.
    Pratap A; Grant D; Vegesna A; Tummalacherla M; Cohan S; Deshpande C; Mangravite L; Omberg L
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e22108. PubMed ID: 33107827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse.
    Eisner E; Drake RJ; Berry N; Barrowclough C; Emsley R; Machin M; Bucci S
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11568. PubMed ID: 30924789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mobile Sensing App to Monitor Youth Mental Health: Observational Pilot Study.
    MacLeod L; Suruliraj B; Gall D; Bessenyei K; Hamm S; Romkey I; Bagnell A; Mattheisen M; Muthukumaraswamy V; Orji R; Meier S
    JMIR Mhealth Uhealth; 2021 Oct; 9(10):e20638. PubMed ID: 34698650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile App for Mental Health Monitoring and Clinical Outreach in Veterans: Mixed Methods Feasibility and Acceptability Study.
    Betthauser LM; Stearns-Yoder KA; McGarity S; Smith V; Place S; Brenner LA
    J Med Internet Res; 2020 Aug; 22(8):e15506. PubMed ID: 32779572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco cessation mobile app intervention (Just Kwit! study): protocol for a pilot randomized controlled pragmatic trial.
    Chu KH; Escobar-Viera CG; Matheny SJ; Davis EM; Primack BA
    Trials; 2019 Feb; 20(1):147. PubMed ID: 30808389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19.
    Sun S; Folarin AA; Ranjan Y; Rashid Z; Conde P; Stewart C; Cummins N; Matcham F; Dalla Costa G; Simblett S; Leocani L; Lamers F; Sørensen PS; Buron M; Zabalza A; Guerrero Pérez AI; Penninx BW; Siddi S; Haro JM; Myin-Germeys I; Rintala A; Wykes T; Narayan VA; Comi G; Hotopf M; Dobson RJ;
    J Med Internet Res; 2020 Sep; 22(9):e19992. PubMed ID: 32877352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to a smartphone application for weight loss compared to website and paper diary: pilot randomized controlled trial.
    Carter MC; Burley VJ; Nykjaer C; Cade JE
    J Med Internet Res; 2013 Apr; 15(4):e32. PubMed ID: 23587561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital phenotyping and the COVID-19 pandemic: Capturing behavioral change in patients with psychiatric disorders.
    Jagesar RR; Roozen MC; van der Heijden I; Ikani N; Tyborowska A; Penninx BWJH; Ruhe HG; Sommer IEC; Kas MJ; Vorstman JAS
    Eur Neuropsychopharmacol; 2021 Jan; 42():115-120. PubMed ID: 33298386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia prediction with the adaboost algorithm.
    Hrdlicka J; Klema J
    Stud Health Technol Inform; 2011; 169():574-8. PubMed ID: 21893814
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.